Risk assessment of endocrine disruptors: Does unresolved uncertainties require extra precaution?
Authors:
- Marie Louise HolmerMHMarie Louise Holmer
- Marta AxelstadMAMarta Axelstad
- Anna BeroniusABAnna Beronius
- Cecile Michel-CailletCMCecile Michel-Caillet
- Terje SvingenTSTerje Svingen
Open Access
- 2 March 2026
- journal article
- Published by Elsevier in Current Opinion in Toxicology
- Vol. 46
Abstract
No abstract availableFunding Information
- Miljøstyrelsen
This publication has 27 references indexed in Scilit:
- Endocrine-disrupting chemicals and reproductive health: With focus on the developmental window of susceptibilityAnnales d'Endocrinologie, 2025
- Exposure to Endocrine Disruptors in Early life and Neuroimaging Findings in Childhood and Adolescence: a Scoping ReviewCurrent Environmental Health Reports, 2024
- Evaluating non-monotonic dose-response relationships in ecotoxicological risk assessment: A case study based on a systematic review of data on fluoxetineChemosphere, 2024
- Thresholds of adversity for endocrine disrupting substances: a conceptual case studyArchives of Toxicology, 2024
- Disruption by stealth - Interference of endocrine disrupting chemicals on hormonal crosstalk with thyroid axis function in humans and other animalsEnvironmental Research, 2022
- Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid2021
- Endocrine disruptors and the developing immune systemCurrent Opinion in Toxicology, 2018
- Low dose effects and non-monotonic dose responses for endocrine active chemicals: Science to practice workshop: Workshop summaryChemosphere, 2013
- Inhibition of Androgen Receptor-Dependent Transcriptional Activity by DDT Isomers and Methoxychlor in HepG2 Human Hepatoma CellsToxicology and Applied Pharmacology, 1998
- Inhibition of brain adenylate cyclase by A1 adenosine receptors: Pharmacological characteristics and locationsBrain Research, 1983